HbA1c Minimally Adds to CVD Risk Prediction in Prediabetes
FRIDAY, Dec. 20, 2019 -- For individuals with prediabetes, hemoglobin A1c (HbA1c) minimally adds to cardiovascular disease (CVD) risk prediction, according to a study published online Dec. 18 in Diabetes Care.
Claire Welsh, Ph.D., from the Institute...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Pharmaceuticals | Study | Wales Health